Observational Study on Second Line Treatment of Liver Metastases With DEBIRI and Cetuximab
Clinical trial NCT01891552 · COMPLETED
Trial details
- NCT number
- NCT01891552
- Sponsor
- International Group of Endovascular Oncology
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2013-05-01
- Primary completion
- 2015-05-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.